The Fluorine-18 Market in North America is witnessing steady growth as fluorine-18-based radiopharmaceuticals continue to support positron emission tomography (PET) imaging and molecular diagnostic applications. Market Overview The fluorine-18 market size is projected to reach US$ 2.53 billion by 2031 from US$ 1.85 billion in 2024. The market is expected to register a CAGR of 4.7%...